September 27, 2016 – Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (the “Company”) is pleased to announce it resumed trading on the TSX Venture Exchange (the “Exchange”) on September 27, 2016 following the close of the acquisition of certain intellectual property and the entering of a joint venture (the “Change of Business”) with CVR Global, Inc. (“CVR Global”) pursuant to the policies of the Exchange.
In connection with the Change of Business, the Company changed its name from “Big Bar Resources Corporation” to “CVR Medical Corp.” pursuant to shareholder approval at a meeting on September 21, 2016. Further, the Company meets the listing requirements of a Tier 2 Life Sciences issuer upon completion of the Change of Business.
Lastly, the Company appointed the following people to their respective positions on close of the Change of Business:
- Peter Bakema as CEO, President, and a Director;
- Paul Blunden as a Director;
- Anthony Robinson as Chief Operations Officer; and
- Jeremy Poirier as a Director.
Concurrently, Bruno Fruscalzo resigned from the Board of Directors of the Company. Mr. Fruscalzo’s resignation was unrelated to the Change of Business.
Further information regarding the Change of Business is contained in the Company’s management filing statement dated September 9, 2016 which is available for viewing on SEDAR at www.sedar.com.
Trading in the securities of the Company should be considered highly speculative. The TSXV has in no way passed upon the merits of the Change of Business and has neither approved nor disapproved the contents of this news release.
Other Information and Updates
Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results in each case could differ materially from those currently anticipated in such statements.